A general enabeling technology for manufacturing pure nanoparticles
|Organization:||Pharmaceutics International Inc., MD, US|
|I.P. Brief:||A novel enabling technique to manufacture nanospheres made entirely from a single material such as carrier-free drug nanoparticles. For example, nanoparticles with 10-200 nanometers diameter can be prepared to improve solubility and dissolution. Surface-modified particles with specific receptor agonists enhances site specific targeting to tissues and cells |
|Keywords:||enabling technology, nanomedicine, manufacturing of nanoparticles, nanomaterials, drug targeting, cancer treatment, hormonal therapy, enhanced absorption|
|Primary Industry:||Pharma & Biotech|
|Specific Market:||Advanced therapy for cancer, hormonal disorders, rhematoid arthritis, pain|
Full IP Descriptions available on-site.